Pre-Clinical Investigation of Anti-TFPI-Mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders

with No hi ha comentaris

Pre-Clinical Investigation of Anti-TFPI-Mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders
Convoca: Pfizer, Inc
Termini: 01/07/2026

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *